Publisher
Springer International Publishing
Reference47 articles.
1. Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, Hayes DF, Lakhani SR, Chavez-MacGregor M, Perlmutter J, Perou CM, Regan MM, Rimm DL, Symmans WF, Torlakovic EE, Varella L, Viale G, Weisberg TF, McShane LM, Wolff AC (2020) Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update. J Clin Oncol 38:1346–1366. https://doi.org/10.1200/JCO.19.02309
2. Banias L, Gurzu S, Kovacs Z et al (2017) Nuclear maspin expression: a biomarker for budding assessment in colorectal cancer specimens. Pathol Res Pract 213:1227–1230. https://doi.org/10.1016/j.prp.2017.07.025
3. Banias L, Jung I, Bara T et al (2020) Immunohistochemical-based molecular subtyping of colorectal carcinomas, using Maspin and markers of epithelial-mesenchymal transition. Oncol Lett 19:1487–1495. https://doi.org/10.3892/ol.2019.11228
4. Barbareschi M, Barberis M, Buttitta F, Doglioni C, Fiorentino M, Fontanini G, Franco R, Marchetti A, Rossi G, Troncone G (2018) Predictive markers in lung cancer: a few hints for the practicing pathologist. Pathologica 110:29–38
5. Birkman EM, Mansuri N, Kurki S, Algars A, Lintunen M, Ristamaki R, Sundstrom J, Carpen O (2018) Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics. Virchows Arch 472:369–382. https://doi.org/10.1007/s00428-017-2240-x